Skip to content
Use caution Medical device recall · FDA · Published May 9, 2024

Philips Tempus LS Defibrillator Recall: Risk of ECG Distortions from Multiple Devices

Philips recalls Tempus LS Manual Defibrillators (part 00-3020) when used with older user manuals. Distortions may cause ineffective pacing or defibrillation. Affected units have serial numbers before 7022.002871 or manual versions prior to 41-3007EN-01.

🇺🇸 FDA recall #Z-2028-2024Medical devicePhilips ›
Take action

Contact the company

Recalling firmRemote Diagnostic Technologies Ltd.Farnborough Aerospace Centre, Aerospace Boulevard · Farnborough, United Kingdom
✎ GovInfoNow plain-language explainer

Philips is recalling Tempus LS Manual Defibrillators that may cause ECG signal distortions if used with older user manuals. This could lead to ineffective pacing or defibrillation, potentially harming patients during critical medical events. Read more at govinfonow.com/recall/55147-philips-tempus-ls-defibrillator-recall-risk-of-ecg-distortions-from.

Source Summary by GovInfoNow · govinfonow.com/recall/55147-philips-tempus-ls-defibrillator-recall-risk-of-ecg-distortions-from · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2028-2024

Cite this page

“Philips Tempus LS Defibrillator Recall: Risk of ECG Distortions from Multiple Devices.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/55147-philips-tempus-ls-defibrillator-recall-risk-of-ecg-distortions-from. Based on FDA recall #Z-2028-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2028-2024%22&limit=1).

The FDA announced on May 9, 2024, that Remote Diagnostic Technologies Ltd. is recalling Philips Tempus LS-Manual Defibrillators with Part Number 00-3020 due to potential ECG signal distortions. The recall affects units with serial numbers prior to 7022.002871 when used with specific user manuals.

How to tell if you have it

  • Brand: Philips
  • Product: Tempus LS-Manual Defibrillator
  • Part Number: 00-3020
  • UDI-DI: 07613365002737
  • Serial Numbers: prior to 7022.002871
  • Manual Versions: 41-3007EN-01 and prior

The hazard

Simultaneous ECG measurements with multiple devices, including a manual defibrillator, on the same patient may cause electrical noise or interference. This interference may lead to distortions of the ECG signal, which could result in no or ineffective pacing, or no or inappropriate defibrillation pulse.

Context

GovInfoNow's records show Remote Diagnostic Technologies Ltd. has 11 other recalls on record since November 17, 2020. Recent brand recalls include a patient monitor measuring Intracranial Pressure and Bladder Pressure without validation (November 26, 2025), an Inseego USB8 4G Dongle Kit with outdated software (May 30, 2025), and a Tempus Pro Patient Monitor software error (April 16, 2025). Other recent recalls of similar products include the Philips Cardiac Workstation 7000 and 5000 inaccurate heart rate data risks (July 1, 2026) and the Philips Allura Xper FD10C Medical System electrical short-circuit risk (December 15, 2025).

How to tell if you have this one

Check the defibrillator's serial number (prior to 7022.002871) or user manual version (prior to 41-3007EN-01). The part number is 00-3020.

  • Brand
    Philips
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check User Manual Version

    Verify your user manual version is 41-3007EN-01 or newer. Older versions may cause ECG distortions.

  2. Review Serial Number

    Check the defibrillator's serial number; units with numbers before 7022.002871 are affected.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 40 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution including in the states of VA, DC, MA, WY, AZ, FL, CA, NM, NJ, TN, OH, KS, IN, NY, IL, TX, NV, NE, PA, AL, IA, GA, MO, KY, WI, OR, CO, WV, WA, ET, UT, ID, OK, MN, ME, MT, MI, NC, ND, MD, DE, VT.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: May 9, 202412. FDA classified it Class II: Jun 6, 202423. Published in FDA’s Enforcement Report: Jun 12, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using the defibrillator immediately?

No. The recall requires checking the user manual version and serial number. Affected units should be updated to the current manual version or replaced.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2028-2024 (May 9, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2028-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA